DISEASE INDICATIONS: Migraine
MANUFACTURER: Amgen Inc. / Novartis Pharmaceuticals Corporation
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Therapeutic Goods Administration (TGA)
Swissmedic (CH)
Medsafe (NZ)
Aimovig is a prescription medication used for preventing migraines in adults. It is an antibody that blocks CGRP receptor, which reduces the frequency and intensity of migraines.